InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: McMagyar post# 16606

Friday, 09/22/2023 11:59:04 AM

Friday, September 22, 2023 11:59:04 AM

Post# of 16696
AGN needs to publish the CHDR DMT peer review, or/and,
AGN needs to sell their IPF/CC trial results and Ifenprodil rights,
these should get the phase 2 of the Microdose DMT / stroke trial started which is the real possible success story here.
All investors in this speculative stock would be real happy for some good overdue news. Many would then show support with some further investments
...IMHFO...
...GLTA...